Press releaseACCESS Newswire
enVVeno Medical
NVNO · NASDAQ
$7.70+$0.01 (+0.13%)TodayMarket closed ·
Prev close $7.69
Latest news
- Press releaseACCESS Newswire
enVVeno Medical Participates in the Virtual Investor 'Why Now' On-Demand Conference
- Press releaseACCESS Newswire
enVVeno Medical Reports Second Quarter 2026 Financial Results and Advances Towards FDA Pivotal Trial for First-in-Class Non-Surgical Replacement Venous Valve
- Press releaseACCESS Newswire
enVVeno Medical Highlights Newly Issued U.S. Patent Strengthening Competitive Position Ahead of Historic Pivotal Trial in Virtual Investor "What This Means" Segment
- Press releaseACCESS Newswire
enVVeno Medical Secures Transformational U.S. Patent for enVVe System, Strengthening Competitive Moat Ahead of Launch of Historic FDA Pivotal Trial
- Press releaseACCESS Newswire
enVVeno Medical Discusses FDA IDE Approval in Virtual Investor "What This Means" Segment
- Press releaseACCESS Newswire
enVVeno Medical Reports First Quarter 2026 Financial Results and Provides Business Update Highlighting Strategic Advancement of the enVVe System
- Press releaseACCESS Newswire
enVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of enVVe(R) System
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- News
12 Health Care Stocks Moving In Friday's After-Market Session
- Press releaseACCESS Newswire
enVVeno Medical (NASDAQ:NVNO) to Participate in a Live Virtual Investor CEO Connect Segment
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- News
12 Health Care Stocks Moving In Friday's After-Market Session
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- NewsAvi Kapoor
Gold Tumbles Over 2%; Cidara Therapeutics Shares Spike Higher
- NewsAvi Kapoor
Nasdaq Dips Over 300 Points; Applied Materials Posts Upbeat Q4 Earnings
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- NewsAvi Kapoor
Why RLX Technology Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
- Press releaseACCESS Newswire
enVVeno Medical (NASDAQ:NVNO) Participates in Virtual Investor "What This Means" Segment
- Press releaseACCESS Newswire
enVVeno Medical Updates Regulatory Status of VenoValve(R)
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- NewsAvi Kapoor
Nasdaq Down 1%; Lowe's Posts Upbeat Earnings
- NewsAvi Kapoor
Dow Surges 100 Points; Target Shares Fall After Q2 Results
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- Press releaseACCESS Newswire
enVVeno Medical Reports Second Quarter 2025 Financial Results and Provides Corporate Update
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Press releaseACCESS Newswire
enVVeno Medical Reports Fourth Quarter and Year-End 2024 Financial Results and Progress Towards VenoValve FDA Approval Expected in 2H25
- Press releaseACCESS Newswire
One-Year Data from the VenoValve(R) U.S. Pivotal Trial Highlighting Impact on Patients' Quality of Life (QOL) to be Presented Today at the 37th Annual Meeting of the American Venous Forum
- Press releaseACCESSWIRE
enVVeno Medical Reports Third Quarter 2024 Financial Results and Confirms Guidance for Release of Definitive VenoValve Data in November and Completion of FDA Premarket Approval Application for VenoValve in Q4 of this Year
- NewsAvi Kapoor
Crude Oil Rises; Onconetix Shares Spike Higher
- NewsAvi Kapoor
Nasdaq Moves Lower; Fed's Preferred Inflation Gauge Falls More Than Projected
- NewsAvi Kapoor
Dow Surges Over 100 Points; Costco Earnings Top Views
- NewsAvi Kapoor
Cassava Sciences, enVVeno Medical And Other Big Stocks Moving Lower In Friday's Pre-Market Session
- NewsAvi Kapoor
Why Establishment Labs Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket
- NewsAvi Kapoor
Costco, Scholastic And 3 Stocks To Watch Heading Into Friday
- Press releaseACCESSWIRE
enVVeno Medical Adds Sandy Prietto to its Executive Team as Vice President of Marketing
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.